Patient
SITE011-0115
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2026-01-21
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 3 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-01-06 (study day 167); relationship: NOT RELATED
Grade 1 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2022-11-08 (study day 108); relationship: RELATED
Grade 2 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-10-28 (study day 97); relationship: not assessed
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-10-22 (study day 91); relationship: not assessed
Grade 2 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2022-10-16 (study day 85); relationship: not assessed
Grade 1 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-10-01 (study day 70); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.